Humacyte, Inc.
HUMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001818382
In the last 90 days, Humacyte, Inc. insiders filed 3 open-market purchases and 0 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $57.3M in total; no superinvestor holds it.
Holders of 5% or more of HUMA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Humacyte, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Fresenius Medical Care Holdings Inc | 13D/A | 11.80%18.3M shares | – | May 22, 20251 filing | May 22, 2025 | SEC |
| Fresenius Medical Care AG | 13D/A | 9.90%18.3M shares | – | Oct 16, 20251 filing | Oct 16, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Humacyte, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Oct 16, 20255:25 PM ET | Fresenius Medical Care AG | 13D/A | 9.90%18.3M shares | – | Oct 8, 2025 | SEC |
| May 22, 20253:23 PM ET | Fresenius Medical Care Holdings Incand 1 other | 13D/A | 11.80%18.3M shares | – | May 13, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Humacyte, Inc. shares.
No Form 144 notices for Humacyte, Inc. are on file.